Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FKEKF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,780
Award facts
- Contract value 100% obligated
- $19,779.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $19,779.72 by the Defense Logistics Agency on August 18, 2025, for the supply of Entyvio 300 mg vials. The contract carries no set-aside designation and has an ultimate completion date of September 9, 2025. The place of performance is located in Park Ridge, Illinois, where the vendor maintains its primary operations.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program, a $499.999 billion vehicle valued through November 2026 that enables the issuance of firm fixed-price delivery orders for pharmaceutical products supporting military health facilities worldwide. Entyvio, a specialized biologic medication used primarily in gastroenterology, represents one of many prescription medications and biologics the vendor distributes as part of its core business serving Department of Defense healthcare systems. DMS Pharmaceutical Group has established itself as a significant supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in federal procurement markets while maintaining a robust portfolio of medical product deliveries to government healthcare facilities.
Quick answers
Who was awarded contract SPE2DB25FKEKF?
SPE2DB25FKEKF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FKEKF worth?
The government has obligated $19,780 on SPE2DB25FKEKF.
Is contract SPE2DB25FKEKF an order under another contract?
Yes. SPE2DB25FKEKF is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEKF competed?
The extent of competition for SPE2DB25FKEKF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award